報價延遲最少15分鐘:2025/06/01 03:50 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
14.54 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-4.38/-2.85
|
|
企業價值
878.21M
|
| 資產負債 |
|
每股賬面淨值
0.62
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
27.12M
|
|
每股收益
2.04
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/01 03:50 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. |